{Reference Type}: Journal Article
{Title}: Current pharmacological treatment guidelines for psoriasis and psoriatic arthritis.
{Author}: Stiff KM;Glines KR;Porter CL;Cline A;Feldman SR;
{Journal}: Expert Rev Clin Pharmacol
{Volume}: 11
{Issue}: 12
{Year}: Dec 2018
{Factor}: 4.108
{DOI}: 10.1080/17512433.2018.1548277
{Abstract}: <B>BACKGROUND: </B>Psoriasis is a common chronic skin condition that is prevalent worldwide. Despite the numerous treatment options available, discrepancies exist between international guidelines. Areas covered: This review aims to evaluate the current international guidelines for the systemic treatment of psoriasis and psoriatic arthritis. Expert commentary: Most guidelines are unanimous on medication dosing and laboratory monitoring. However, even the most up-to-date guidelines do not include many of the new biologic medications. Guidelines will require frequent updates to include the newer treatments and will soon need to state a recommendation on the use of biosimilars.